1048 related articles for article (PubMed ID: 18403496)
1. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
[TBL] [Abstract][Full Text] [Related]
2. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
4. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
[TBL] [Abstract][Full Text] [Related]
5. Is ineffective oesophageal motility associated with reflux oesophagitis?
Fornari F; Callegari-Jacques SM; Scussel PJ; Madalosso LF; Barros EF; Barros SG
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):783-7. PubMed ID: 17700264
[TBL] [Abstract][Full Text] [Related]
6. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
[TBL] [Abstract][Full Text] [Related]
7. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021
[TBL] [Abstract][Full Text] [Related]
8. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
9. Leptin and the risk of Barrett's oesophagus.
Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC;
Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609
[TBL] [Abstract][Full Text] [Related]
10. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
[TBL] [Abstract][Full Text] [Related]
11. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
Ortiz Escandell A; Martínez de Haro LF; Parrilla Paricio P; Molina Martínez J; Aguayo Albasini JL; Martínez Gómez D
Rev Esp Enferm Dig; 1990 Mar; 77(3):171-5. PubMed ID: 2378753
[TBL] [Abstract][Full Text] [Related]
12. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
13. Reflux oesophagitis in Italy (Diomede project).
Baldi F; Cavoli C; Solimando R; Bianco MA; Cipolletta L; Costamagna G; Passaretti S
Dig Liver Dis; 2008 Jun; 40(6):405-11. PubMed ID: 18294931
[TBL] [Abstract][Full Text] [Related]
14. Importance of duodenogastric reflux in gastro-oesophageal reflux disease.
Fein M; Maroske J; Fuchs KH
Br J Surg; 2006 Dec; 93(12):1475-82. PubMed ID: 17051600
[TBL] [Abstract][Full Text] [Related]
15. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage.
Bredenoord AJ; Hemmink GJ; Smout AJ
Neurogastroenterol Motil; 2009 Aug; 21(8):807-12. PubMed ID: 19374635
[TBL] [Abstract][Full Text] [Related]
16. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.
Roman S; Kahrilas PJ
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):17-28. PubMed ID: 25743453
[TBL] [Abstract][Full Text] [Related]
18. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
Rosaida MS; Goh KL
Eur J Gastroenterol Hepatol; 2004 May; 16(5):495-501. PubMed ID: 15097043
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus.
Parrilla P; Ortiz A; Martinez de Haro LF; Aguayo JL; Ramirez P
Gut; 1990 Sep; 31(9):964-7. PubMed ID: 2210462
[TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus in females: a comparative analysis of risk factors in females and males.
Banki F; Demeester SR; Mason RJ; Campos G; Hagen JA; Peters JH; Bremner CG; Demeester TR
Am J Gastroenterol; 2005 Mar; 100(3):560-7. PubMed ID: 15743352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
